Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
The originally published version of this Article contained an error in Figure 6. In panel b, the top graph (BrdU 21–24d) and the bottom graph (BrdU 28–31d) were inadvertently swapped. This error has now been corrected in both the PDF and HTML versions of the Article.
Main Authors: | James S. Novak, Marshall W. Hogarth, Jessica F. Boehler, Marie Nearing, Maria C. Vila, Raul Heredia, Alyson A. Fiorillo, Aiping Zhang, Yetrib Hathout, Eric P. Hoffman, Jyoti K. Jaiswal, Kanneboyina Nagaraju, Sebahattin Cirak, Terence A. Partridge |
---|---|
格式: | Article |
語言: | English |
出版: |
Nature Portfolio
2018-03-01
|
叢編: | Nature Communications |
在線閱讀: | https://doi.org/10.1038/s41467-018-03709-8 |
相似書籍
-
Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
由: James S. Novak, et al.
出版: (2017-10-01) -
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
由: James S. Novak, et al.
出版: (2018-01-01) -
Shorter Phosphorodiamidate Morpholino Splice-Switching Oligonucleotides May Increase Exon-Skipping Efficacy in DMD
由: Ugur Akpulat, et al.
出版: (2018-12-01) -
The use of urinary and kidney SILAM proteomics to monitor kidney response to high dose morpholino oligonucleotides in the mdx mouse
由: Aiping Zhang, et al.
出版: (2015-01-01) -
Defining synphenotype groups in Xenopus tropicalis by use of antisense morpholino oligonucleotides.
由: Amer Ahmed Rana, et al.
出版: (2006-11-01)